athenahealth Inc. (NASDAQ:ATHN)’s share price was up 3.2% during mid-day trading on Tuesday . The stock traded as high as $127.98 and last traded at $127.74, with a volume of 314,370 shares traded. The stock had previously closed at $123.73.

Several equities analysts recently issued reports on ATHN shares. Zacks Investment Research cut athenahealth from a “buy” rating to a “hold” rating in a research note on Wednesday, May 4th. Vetr lowered athenahealth from a “sell” rating to a “strong sell” rating and set a $121.08 target price on the stock. in a research report on Tuesday, March 29th. Deutsche Bank AG reaffirmed a “buy” rating on shares of athenahealth in a research report on Tuesday, April 5th. Morgan Stanley dropped their target price on athenahealth from $186.00 to $153.00 and set an “overweight” rating on the stock in a research report on Monday. Finally, Piper Jaffray Cos. reaffirmed an “overweight” rating and issued a $174.00 target price on shares of athenahealth in a research report on Tuesday, May 17th. Four research analysts have rated the stock with a sell rating, eight have issued a hold rating and nine have issued a buy rating to the company. athenahealth currently has a consensus rating of “Hold” and a consensus price target of $149.58.

The company has a market capitalization of $5.08 billion and a price-to-earnings ratio of 475.00. The firm’s 50-day moving average price is $133.90 and its 200-day moving average price is $134.16.

athenahealth (NASDAQ:ATHN) last posted its quarterly earnings data on Thursday, July 21st. The company reported $0.34 earnings per share for the quarter, missing the consensus estimate of $0.42 by $0.08. The firm earned $261.90 million during the quarter, compared to the consensus estimate of $274.07 million. Equities research analysts expect that athenahealth Inc. will post $1.77 earnings per share for the current fiscal year.

In other news, Director Brandon H. Hull sold 800 shares of the company’s stock in a transaction dated Monday, May 2nd. The stock was sold at an average price of $132.74, for a total transaction of $106,192.00. Following the completion of the transaction, the director now directly owns 7,987 shares of the company’s stock, valued at $1,060,194.38. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Kristi Ann Matus sold 415 shares of the company’s stock in a transaction dated Monday, May 2nd. The stock was sold at an average price of $133.27, for a total value of $55,307.05. Following the transaction, the executive vice president now directly owns 34,116 shares of the company’s stock, valued at $4,546,639.32. The disclosure for this sale can be found here.

Several hedge funds and institutional investors have recently bought and sold shares of the company. Trexquant Investment LP purchased a new position in athenahealth during the fourth quarter valued at $1,193,000. Advisors Asset Management Inc. boosted its position in shares of athenahealth by 62.6% in the fourth quarter. Advisors Asset Management Inc. now owns 7,811 shares of the company’s stock valued at $1,257,000 after buying an additional 3,007 shares during the period. Marshall Wace LLP boosted its position in shares of athenahealth by 188.0% in the fourth quarter. Marshall Wace LLP now owns 37,199 shares of the company’s stock valued at $5,988,000 after buying an additional 24,284 shares during the period. Atlanta Capital Group boosted its position in shares of athenahealth by 21.0% in the fourth quarter. Atlanta Capital Group now owns 8,359 shares of the company’s stock valued at $1,346,000 after buying an additional 1,448 shares during the period. Finally, Suntrust Banks Inc. boosted its position in shares of athenahealth by 0.4% in the fourth quarter. Suntrust Banks Inc. now owns 10,112 shares of the company’s stock valued at $1,627,000 after buying an additional 44 shares during the period.

athenahealth, Inc is a provider of cloud-based services and mobile applications for medical groups and health systems. The Company delivers cloud-based services for revenue cycle management and medical billing, electronic health records (EHR), patient engagement, care coordination, order transmission, population health management, and clinical decision support.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.